Final height in girls with turner syndrome after long-term growth hormone treatment in three dosages and low dose estrogens

Journal of Clinical Endocrinology and Metabolism

Volumn 88, Issue 3, 2003, Pages 1119-1125

  Van Pareren, Yvonne K ^a   De Muinck Keizer Schrama, Sabine M P F ^a   Stijnen, Theo ^b   Sas, Theo C J ^a   Jansen, Maarten ^c   Otten, Barto J ^d   Hoorweg Nijman, J J Gera ^e   Vulsma, Thomas ^f   Stokvis Brantsma, Wilhelmina H ^g   Rouwé, Catrienus W ^h   Reeser, H Maarten ⁱ   Gerver, Willem Jan ^j   Gosen, Jos J ^k   Rongen Westerlaken, Ciska ^l   Drop, Stenvert L S ^a  

^a SOPHIA CHILDREN S HOSPITAL   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^d RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^e VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^f EMMA CHILDREN S HOSPITAL   (Netherlands)

^g LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^h UNIVERSITY OF GRONINGEN   (Netherlands)

ⁱ JULIANA CHILDREN S HOSPITAL   (Netherlands)

^j MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^k RIJNLAND HOSPITAL   (Netherlands)

^l CANISIUS WILHELMINA HOSPITAL   (Netherlands)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ESTRADIOL; GROWTH HORMONE;

AGE; ARTICLE; BODY HEIGHT; BONE MATURATION; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; FEMALE; GROWTH RATE; HORMONE SUBSTITUTION; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; MULTICENTER STUDY; PRIORITY JOURNAL; PUBERTY; RANDOMIZED CONTROLLED TRIAL; SHORT STATURE; TURNER SYNDROME;

BODY HEIGHT; CHILD; CHILD, PRESCHOOL; DOSE-RESPONSE RELATIONSHIP, DRUG; ESTRADIOL; FEMALE; HUMAN GROWTH HORMONE; HUMANS; INSULIN-LIKE GROWTH FACTOR I; TURNER SYNDROME;

EID: 0037340318     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.2002-021171     Document Type: Article

References (32)

1. Rao E, Weiss B, Fukami M, Rump A, Niesler B, Mertz A, Muroya K, Binder G, Kirsch S, Winkelmann M, Nordsiek G, Heinrich U, Breuning MH, Ranke MB, Rosenthal A, Ogata T, Rappold GA 1997 Pseudoautosomal deletions encompassing a novel homeobox gene cause growth failure in idiopathic short stature and Turner syndrome. Nat Genet 16:54-63
2. Wit JM, Massarano AA, Kamp GA, Hindmarsh PC, van Es A, Brook CG, Preece MA, Matthews DR 1992 Growth hormone secretion in patients with Turner's syndrome as determined by time series analysis. Acta Endocrinol (Copenh) 127:7-12
3. Ranke MB, Blum WF, Haug F, Rosendahl W, Attanasio A, Enders H, Gupta D, Bierich JR 1987 Growth hormone, somatomedin levels and growth regulation in Turner's syndrome. Acta Endocrinol (Copenh) 116:305-313
4. Sas TC, de Muinck Keizer-Schrama SM, Stijnen T, Jansen M, Otten BJ, Hoorweg-Nijman JJ, Vulsma T, Massa GG, Rouwe CW, Reeser HM, Gerver WJ, Gosen JJ, Rongen-Westerlaken C, Drop SL 1999 Normalization of height in girls with Turner syndrome after long-term growth hormone treatment: results of a randomized dose-response trial. J Clin Endocrinol Metab 84:4607-4612
5. Van Vliet G 1988 Hormonal changes during development in Turner's syndrome. Acta Paediatr Scand 343(Suppl):31-37
6. Boguszewski CL, Jansson C, Boguszewski MC, Rosberg S, Carlsson B, Albertsson-Wikland K, Carlsson LM 1997 Increased proportion of circulating non-22-kilodalton growth hormone isoforms in short children: a possible mechanism for growth failure. J Clin Endocrinol Metab 82:2944-2949
7. Rosenfeld RG, Attie KM, Frane J, Brasel JA, Burstein S, Cara JF, Chernausek S, Gotlin RW, Kuntze J, Lippe BM, Mahoney CP, Moore WV, Saenger P, Johanson AJ 1998 Growth hormone therapy of Turner's syndrome: beneficial effect on adult height. J Pediatr 132:319-324
8. Taback SP, Collu R, Deal CL, Guyda HJ, Salisbury S, Dean HJ, Van Vliet G 1996 Does growth-hormone supplementation affect adult height in Turner's syndrome? Lancet 348:25-27
9. Sas TC, de Muinck Keizer-Schrama SM, Stijnen T, van Teunenbroek A, Hokken-Koelega AC, Waelkens JJ, Massa GG, Vulsma T, Gerver WJ, Reeser HM, Delemarre-van de Waal HE, Jansen M, Drop SL 1999 Final height in girls with Turner's syndrome treated with once or twice daily growth hormone injections. Dutch Advisory Group on Growth Hormone. Arch Dis Child 80:36-41
10. van Teunenbroek A, de Muinck Keizer-Schrama SM, Stijnen T, Jansen M, Otten BJ, Delemarre-van de Waal HA, Vulsma T, Wit JM, Rouwe CW, Reeser HM, Gosen JJ, Rongen-Westerlaken C, Drop SL 1996 Yearly stepwise increments of the growth hormone dose results in a better growth response after four years in girls with Turner syndrome. Dutch Working Group on Growth Hormone. J Clin Endocrinol Metab 81:4013-4021
11. Roede MJ, van Wieringen JC 1985 Growth diagrams 1980. Netherlands third nation-wide survey. Tijdschr Soc Gezondh 63(Suppl):1-34
12. Tanner JM, Whitehouse RH 1976 Clinical longitudinal standards for height, weight, height velocity, weight velocity, and stages of puberty. Arch Dis Child 51:170-179
13. Fredriks AM, van Buuren S, Burgmeijer RJ, Meulmeester JF, Beuker RJ, Brugman E, Roede MJ, Verloove-Vanhorick SP, Wit JM 2000 Continuing positive secular growth change in The Netherlands 1955-1997. Pediatr Res 47:316-323
14. Karlberg J, Albertsson-Wikland K, Naeraa RW, Rongen-Westerlaken C, Wit JM 1992 Reference values for spontaneous growth in Turner girls and its use in estimating treatment effects. In: Hibi I, Takano K, eds. Basic and clinical approach to Turner syndrome: 3rd International Symposium on Turner Syndrome; 1992 8-10 July; Chiba, Japan. Amsterdam: Elsevier; 83-92
15. Rongen-Westerlaken C, Corel L, van den Broeck J, Massa G, Karlberg J, Albertsson-Wikland K, Naeraa RW, Wit JM 1997 Reference values for height, height velocity and weight in Turner's syndrome. Swedish Study Group for GH treatment. Acta Paediatr 86:937-942
16. de Muinck Keizer-Schrama SM 1998 Consensus "diagnosis of short stature in children." National Organization for Quality Assurance in Hospitals. Ned Tijdschr Geneeskd 142:2519-2525
17. Tanner J, Whitehouse R, Cameron N, Marshall W, Healy M, Goldstein H 1983 Assessment of skeletal maturity and prediction of adult height (TW2-method), 2nd Ed. London: Academic Press
18. Lyon AJ, Preece MA, Grant DB 1985 Growth curve for girls with Turner syndrome. Arch Dis Child 60:932-935
19. van Teunenbroek A, Stijnen T, Otten B, de Muinck Keizer-Schrama S, Naeraa RW, Rongen-Westerlaken C, Drop S 1996 A regression method including chronological and bone age for predicting final height in Turner's syndrome, with a comparison of existing methods. Acta Paediatr 85:413-420
20. van Teunenbroek A, de Muinck Keizer-Schrama SM, Stijnen T, Mouton JW, Blum WF, Mercado M, Baumann G, Drop SL 1993 Effect of growth hormone administration frequency on 24-hour growth hormone profiles and levels of other growth related parameters in girls with Turner's syndrome. Dutch Working Group on Growth Hormone. Clin Endocrinol (Oxf) 39:77-84
21. Rikken B, van Doorn J, Ringeling A, Van den Brande JL, Massa G, Wit JM 1998 Plasma levels of insulin-like growth factor (IGF)-I, IGF-II and IGF-binding protein-3 in the evaluation of childhood growth hormone deficiency. Horm Res 50:166-176
22. Sas TC, de Muinck Keizer-Schrama SM, Stijnen T, Aanstoot HJ, Drop SL 2000 Carbohydrate metabolism during long-term growth hormone (GH) treatment and after discontinuation of GH treatment in girls with Turner syndrome participating in a randomized dose-response study. Dutch Advisory Group on Growth Hormone. J Clin Endocrinol Metab 85:769-775
23. Hochberg Z, Zadik Z 1999 Final height in young women with Turner syndrome after GH therapy: an open controlled study. Eur J Endocrinol 141:218-224
24. Nilsson KO, Albertsson-Wikland K, Alm J, Aronson S, Gustafsson J, Hagenas L, Hager A, Ivarsson SA, Karlberg J, Kristrom B, Marcus C, Moell C, Ritzen M, Tuvemo T, Wattsgard C, Westgren U, Westphal O, Aman J 1996 Improved final height in girls with Turner's syndrome treated with growth hormone and oxandrolone. J Clin Endocrinol Metab 81:635-640
25. Chernausek SD, Attie KM, Cara JF, Rosenfeld RG, Frane J 2000 Growth hormone therapy of Turner syndrome: the impact of age of estrogen replacement on final height. Genentech, Inc., Collaborative Study Group. J Clin Endocrinol Metab 85:2439-2445
26. Reiter EO, Blethen SL, Baptista J, Price L 2001 Early initiation of growth hormone treatment allows age-appropriate estrogen use in turner's syndrome. J Clin Endocrinol Metab. 86:1936-1941
27. Carel JC, Mathivon L, Gendrel C, Ducret JP, Chaussain JL 1998 Near normalization of final height with adapted doses of growth hormone in Turner's syndrome. J Clin Endocrinol Metab 83:1462-146
28. Cacciari E, Mazzanti L 1999 Final height of patients with Turner's syndrome treated with growth hormone (GH): indications for GH therapy alone at high doses and late estrogen therapy. Italian Study Group for Turner Syndrome. J Clin Endocrinol Metab 84:4510-4515
29. Ross JL, McCauley E, Roeltgen D, Long L, Kushner H, Feuillan P, Cutler Jr GB 1996 Self-concept and behavior in adolescent girls with Turner syndrome: potential estrogen effects. J Clin Endocrinol Metab 81:926-931
30. Massa G, Maes M, Heinrichs C, Vandeweghe M, Craen M, Vanderschueren-Lodeweyckx M 1993 Influence of spontaneous or induced puberty on the growth promoting effect of treatment with growth hormone in girls with Turner's syndrome. Clin Endocrinol (Oxf) 38:253-260
31. Ma J, Pollak MN, Giovannucci E, Chan JM, Tao Y, Hennekens CH, Stampfer MJ 1999 Prospective study of colorectal cancer risk in men and plasma levels of insulin-like growth factor (IGF)-I and IGF-binding protein-3. J Natl Cancer Inst 91:620-625
32. Hankinson SE, Willett WC, Colditz GA, Hunter DJ, Michaud DS, Deroo B, Rosner B, Speizer FE, Pollak M 1998 Circulating concentrations of insulin-like growth factor-I and risk of breast cancer. Lancet 351:1393-136